Songwon Industrial (004430)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 10,180.00 |
|---|---|
| 52-week range | 8,470.00 – 16,730.00 |
| Return, 1 month / 3 months | −9.8% / −21.7% |
| Return, 1 year / 3 years | +5.9% / −39.8% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 48.4% |
| Worst drawdown (1 year) | -40.5% |
| Average daily value traded | 1,744.29M KRW |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Songwon Industrial is a South Korean chemicals company based in Ulsan that makes additives for plastics and other materials. Its products include antioxidants, light stabilizers and stabilizers for polyvinyl chloride, which help manufacturers keep polymers from degrading during processing and use. The company supplies these specialty chemicals to producers of plastics, coatings and related industrial materials, serving customers in many countries through its manufacturing and sales operations.
The shares are listed on the Korea Stock Exchange in Korea under the code 004430, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Songwon Industrial (004430) trades on the Korea Stock Exchange in Korea. It last closed at KRW 10,180.00 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 277 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.9% and over the last three months it fell 21.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -35.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -21.7% | ||
| 6-month return | -4.3% | ||
| 12-month return, skipping the last month | 17.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 48.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.5% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,744.29M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.3% |
|---|---|
| 1 month | −9.8% |
| 3 months | −21.7% |
| 6 months | −4.3% |
| 1 year | +5.9% |
| 3 years | −39.8% |
| 5 years | −34.3% |
Signals
| 50-day / 200-day average | 11,481.80 / 10,532.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 394.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 300.0000 |
| 28 Mar 2025 | KRW 300.0000 |
| 27 Dec 2023 | KRW 250.0000 |
| 28 Dec 2022 | KRW 500.0000 |
| 29 Dec 2021 | KRW 200.0000 |
| 29 Dec 2020 | KRW 120.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.